Nykode Therapeutics
Biotechnology ResearchOslo, Norway51-200 Employees
We are a leading technology platform that unlocks unlimited possibilities for the future of medicine through our intelligent modular design and tailored hyper targeting.
Insights
Autoimmune Disease Focus Nykode Therapeutics is actively developing antigen-specific treatments for autoimmune diseases by leveraging its APC-targeting platform. This focus presents a significant opportunity for sales in the field of autoimmune disease therapeutics.
Clinical Collaboration Expansion The recent clinical collaboration with MSD to evaluate VB10.16 in combination with KEYTRUDA(R) in cervical cancer patients showcases Nykode's strategic partnerships. Sales teams can leverage this collaboration for further business development in the oncology market.
Inverse Vaccine Advancements Nykode's updates on the inverse vaccine platform, especially in treating autoimmune diseases, provide a unique selling point for sales engagements. Highlighting these advancements can attract partnerships and sales opportunities within the immunotherapy sector.
Financial Growth Potential With a recent IPO financing of $45.1M and revenue ranging between $10M - $50M, Nykode Therapeutics demonstrates growth potential. Sales development representatives can target potential investors, partners, and customers based on the company's financial health.
Strategic Partnerships with Roche Partnerships with industry giants like Roche for upcoming trials in cervical cancer indicate Nykode's credibility and reach. Sales teams can capitalize on these collaborations to create business opportunities and enhance market presence.
Similar companies to Nykode Therapeutics
Chimeric Therapeutics
12
$10MCybrexa Therapeutics
20$10MImmco Diagnostics
51$10M$50MAro Biotherapeutics
50$10M
Nykode Therapeutics Tech Stack
Nykode Therapeutics uses 8 technology products and services including Cookie Notice, CookieYes, Microsoft 365, and more. Explore Nykode Therapeutics's tech stack below.
- Cookie NoticeCookie Compliance
- CookieYesCookie Compliance
- Microsoft 365Email
- AOSJavascript Libraries
- Amazon ALBLoad Balancers
- Open GraphMiscellaneous
- Microsoft AzurePlatform As A Service
- Yoast SEOSearch Engines
Media & News
Nykode Therapeutics's Email Address Formats
Nykode Therapeutics uses at least 2 format(s):
| Nykode Therapeutics Email Formats | Percentage |
| FLast@vaccibody.com | 55% |
| F.Last@vaccibody.com | 14% |
| FMLast@vaccibody.com | 7% |
| FL@vaccibody.com | 6% |
| First.Last@vaccibody.com | 5% |
| FMiddleLast@vaccibody.com | 4% |
| FirstLast@vaccibody.com | 2% |
| First.L@vaccibody.com | 2% |
| First.Middle.Last@vaccibody.com | 1% |
| FirstLas@vaccibody.com | 1% |
| LFirst@vaccibody.com | 1% |
| First_Last@vaccibody.com | 1% |
| LastFir@vaccibody.com | 1% |
| FLast@nykode.com | 67% |
| FLast@nykode.com | 16% |
| FLast@nykode.com | 17% |
Frequently Asked Questions
Where is Nykode Therapeutics's headquarters located?
Nykode Therapeutics's main headquarters is located at Gaustadalléen 21 Oslo, 0349 NO. The company has employees across 3 continents, including EuropeNorth AmericaAsia. What is Nykode Therapeutics's official website and social media links?
Nykode Therapeutics's official website is nykode.com and has social profiles on LinkedIn.How much revenue does Nykode Therapeutics generate?
As of October 2024, Nykode Therapeutics's annual revenue reached $35M. What is Nykode Therapeutics's SIC code NAICS code?
Nykode Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Nykode Therapeutics have currently?
As of October 2024, Nykode Therapeutics has approximately 185 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Development Officer: K. E.Chief Business Officer: A. F.Chief Scientific Officer: M. W. P.. Explore Nykode Therapeutics's employee directory with LeadIQ.What industry does Nykode Therapeutics belong to?
Nykode Therapeutics operates in the Biotechnology Research industry. What technology does Nykode Therapeutics use?
Nykode Therapeutics's tech stack includes Cookie NoticeCookieYesMicrosoft 365AOSAmazon ALBOpen GraphMicrosoft AzureYoast SEO. What is Nykode Therapeutics's email format?
Nykode Therapeutics's email format typically follows the pattern of . Find more Nykode Therapeutics email formats with LeadIQ. How much funding has Nykode Therapeutics raised to date?
As of October 2024, Nykode Therapeutics has raised $25M in funding. The last funding round occurred on Dec 16, 2016 for $25M.When was Nykode Therapeutics founded?
Nykode Therapeutics was founded in 2007.
Company Overview
- Headquarters
- Gaustadalléen 21 Oslo, 0349 NO
- Website
- nykode.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2007
- Employees
- 51-200
Media & News
Funding & Financials
- $25M
Nykode Therapeutics has raised a total of $25M of funding over 4 rounds. Their latest funding round was raised on Dec 16, 2016 in the amount of $25M.
- $10M$50M
Nykode Therapeutics's revenue is in the range of $10M$50M
Funding & Financials
- $25M
Nykode Therapeutics has raised a total of $25M of funding over 4 rounds. Their latest funding round was raised on Dec 16, 2016 in the amount of $25M.
- $10M$50M
Nykode Therapeutics's revenue is in the range of $10M$50M
Company Leadership
K. E.Chief Development Officer
A. F.Chief Business Officer- M. W. P.Chief Scientific Officer
- H. G.Chief Financial Officer
S. T.Chief Medical Officer
Employee Directory
- H. G.Chief Financial Officer
- M. H.Cto
- S. T.Chief Medical Officer
- H. S.Chief Accounting Officer
- L. K.Vp, Head Of Business Development
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
